Evidence map›Paper›PMID 32880764›Full record

ReviewCurrent psychiatry reports2020

Digital Health Around Clinical High Risk and First-Episode Psychosis.

Philip Henson, Hannah Wisniewski, Charles Stromeyer Iv, John Torous

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current psychiatry reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philip HensonBeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.
Hannah WisniewskiBeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA.
Charles Stromeyer IvConsumer Advisory Board, Massachusetts Mental Health Center, Boston, MA, 02115, USA.
John TorousBeth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA, 02215, USA. jtorous@bidmc.harvard.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review aims to examine relapse definitions and risk factors in psychosis as well as the role of technology in relapse predictions and risk modeling. RECENT

findingsThere is currently no standard definition for relapse. Therefore, there is a need for data models that can account for the variety of factors involved in defining relapse. Smartphones have the ability to capture real-time, moment-to-moment assessment symptomology and behaviors via their variety of sensors and have high potential to be used to create prediction and risk modeling. While there is still a need for further research on how technology can predict and model relapse, there are simple ways to begin incorporating technology for relapse prediction in clinical care.

Indexed as

Psychotic DisordersHumansRecurrenceRisk FactorsFirst-episode psychosisRelapseSmartphonesTechnology

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.